Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Tumour prevention and rejection with recombinant vaccinia

Abstract

Tumour-specific antigens (TSA; ref. 1) have been exploited in the diagnosis2 and imaging3 of human cancer and anti-TSA antibodies have therapeutic potential4. Vaccination with TSA5–8 or anti-idiotypic (TSA) antibodies9,10 has also been used to control tumour growth in model systems. An effective immune response nevertheless demands copresentation of antigen with host histocompatibility determinants11. We therefore examined whether live vaccinia virus recombinants expressing TSA in cells of the vaccinated host might better elicit tumour immunity. Polyoma virus (PY) is tumorigenic in rodents; because killed PY-transformed cells can elicit tumour immunity, a PY-specific TSA has been postulated12–14. Tumorigenesis involves expression of three early PY proteins15‐17, large-T (LT), middle-T (MT) and small-T (ST), but their role as TSAs is unclear. We therefore expressed the three T proteins in separate vaccinia recombinants. Rejection of PY tumours was observed in rats immunized with recombinants expressing either LT or MT. Further, tumour-bearing animals could be induced to reject their tumours by inoculation of recombinants.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Hellström, K. E., Hellström, I. & Brown, J. P. Springer Semin. Immunopalh. 5, 127–146 (1982).

    Google Scholar 

  2. Herlyn, M., Blaszczyk, M. & Koprowski, H. Contr. Oncol. 19, 160–170 (1984).

    Google Scholar 

  3. Begent, R. H. J. Biochem. biophys. Acta 780, 151–166 (1985).

    CAS  PubMed  Google Scholar 

  4. Miller, R. A. et al. Hybridomus in Cancer Diagnosis and Treatment (eds Mitchell, M. S. & Oettgen, H. F.) 133–140 (Raven, New York, 1982).

    Google Scholar 

  5. Gross, L. Cancer Res. 3, 326–333 (1943).

    Google Scholar 

  6. Foley, E. J. Cancer Res. 13, 835–837 (1953).

    CAS  PubMed  Google Scholar 

  7. Prehn, R. T. & Main, J. M. J. natn. Cancer Inst. 18, 769–778 (1957).

    CAS  Google Scholar 

  8. Tevethia, S. S., Flyer, D. C. & Tijan, R. Virology 107, 13–23 (1980).

    CAS  PubMed  Google Scholar 

  9. Lee, V. K. et al. Proc. natn. Acad. Sci. U.S.A. 82, 6286–6290 (1985).

    ADS  CAS  Google Scholar 

  10. Herlyn, D., Ross, A. H. & Koprowski, H. Science 232, 100–102 (1986).

    ADS  CAS  PubMed  Google Scholar 

  11. Zinkernagel, R. M. & Doherty, P. C. Adv. Immun. 27, 51–177 (1979).

    CAS  PubMed  Google Scholar 

  12. Sjogren, H. O., Hellström, I. & Klein, I. Cancer Res. 21, 329–337 (1961).

    Google Scholar 

  13. Habel, K. Proc. Soc. exp. Biol. Med. 106, 722–725 (1961).

    CAS  PubMed  Google Scholar 

  14. Ito, Y., Brocklehurst, J. R. & Dulbecco, R. Proc. natn. Acad. Sci. U.S.A. 74, 4666–4670 (1977).

    ADS  CAS  Google Scholar 

  15. Basilico, C. Pharmac. Ther. 26, 235–272 (1984).

    CAS  Google Scholar 

  16. Griffin, B. E. & Dilworth, S. M. Adv. Cancer Res. 39, 183–268 (1983).

    CAS  PubMed  Google Scholar 

  17. Tooze, J. DNA Tumor Viruses (Cold Spring Harbor Laboratory, New York, 1981).

    Google Scholar 

  18. Panicali, D. & Paoletti, E. Proc. natn. Acad. Sci. U.S.A. 79, 4927–4931 (1982).

    ADS  CAS  Google Scholar 

  19. Mackett, M., Smith, G. L. & Moss, B. Proc. natn. Acad. Sci. U.S.A. 79, 7415–7419 (1982).

    ADS  CAS  Google Scholar 

  20. Smith, G. L., Mackett, M. & Moss, B. Biolechnol. Genet. Engng. Reu. 2, 383–407 (1984).

    CAS  Google Scholar 

  21. Kieny, M. P. et al. Nature 312, 163–166 (1984).

    ADS  CAS  PubMed  Google Scholar 

  22. Wiktor, T. J. et al. Proc. natn. Acad. Sci. U.S.A. 81, 7194–7198 (1984).

    ADS  CAS  Google Scholar 

  23. Wiktor, T. J., Kieny, M. P. & Lathe, R. Appl. Virol. Res. (in the press).

  24. Bennink, J. R., Yewdell, J. W., Smith, G. L., Moller, C. & Moss, B. Nature 311, 578–579 (1984).

    ADS  CAS  PubMed  Google Scholar 

  25. McMichael, A. J., Michie, C. A., Gotch, F. M., Smith, G. L. & Moss, B. J. gen. Virol 67, 719–726 (1986).

    CAS  PubMed  Google Scholar 

  26. Hellström, K. E. & Hellström, I. Adv. Cancer Res. 12, 167–223 (1969).

    PubMed  Google Scholar 

  27. Heberman, R. B. Adv. Cancer Res. 19, 207–263 (1974).

    Google Scholar 

  28. Treisraan, R., Novak, U., Favaloro, J. & Kamen, R. Nature 292, 595–600 (1981).

    ADS  Google Scholar 

  29. Rassoulzadegan, M. et al. Nature 300, 713–718 (1982).

    ADS  CAS  PubMed  Google Scholar 

  30. Takemoto, K. K., Malmgren, R. A. & Habel, K. Virology 28, 485–488 (1966).

    CAS  PubMed  Google Scholar 

  31. Zhu, Z. et al. J. Virol. 51, 170–180 (1984).

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Dilworth, S. M. et al. EMBO J. 5, 491–499 (1986).

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Schaffhausen, B. S., Dorai, H., Arakere, G. & Benjamin, T. L. Molec. cell. Biol. 2, 1187–1198 (1982).

    CAS  PubMed  Google Scholar 

  34. Old, L. J., Clarke, D. A. & Benacerraf, B. Nature 184, 291–292 (1959).

    ADS  PubMed  Google Scholar 

  35. Koprowski, H. & Norton, T. W. Cancer 3, 874–885 (1950).

    CAS  PubMed  Google Scholar 

  36. Froscher, B. G. & Klinman, N. R. J. exp. Med. 164, 196–210 (1986).

    CAS  PubMed  Google Scholar 

  37. Dalianis, T., Ramqvist, T. & Klein, G. Int. J. Cancer 34, 403–406 (1984).

    CAS  PubMed  Google Scholar 

  38. Sharma, S., Rodgers, L., Brandsma, J., Gething, M. J. & Sambrook, J. EMBO J. 4, 1479–1489 (1985).

    CAS  PubMed  PubMed Central  Google Scholar 

  39. Bennink, J. R., Yewdell, J. W. & Gerhard, W. Nature 296, 75–76 (1982).

    ADS  CAS  PubMed  Google Scholar 

  40. Townsend, A. R. M., McMichael, A. J., Carter, N. P., Haddleston, J. A. & Brownlee, G. G. Cell 39, 13–25 (1984).

    CAS  PubMed  Google Scholar 

  41. Yewdell, J. W., Bennink, J. R., Smith, G. L. & Moss, B. Proc. natn. Acad. Sci. U.S.A. 82, 1785–1789 (1985).

    ADS  CAS  Google Scholar 

  42. Koprowski, H., Herlyn, M., Steplewski, Z. & Sears, H. F. Science 212, 53–56 (1981).

    ADS  CAS  PubMed  Google Scholar 

  43. Real, F. X. et al. J. exp. Med. 160, 1219–1233 (1984).

    CAS  PubMed  Google Scholar 

  44. Ueda, R. et al. J. exp. Med. 150, 564–572 (1979).

    CAS  PubMed  Google Scholar 

  45. Drebin, J. A., Stern, D. F., Link, V. C., Weinberg, R. A. & Greene, M. I. Nature 312, 545–548 (1984).

    ADS  CAS  PubMed  Google Scholar 

  46. Peto, R. & Zur Hausen, H. (eds) Banbury Report 21, Viral Etiology of Cervical Cancer (Cold Spring Harbor Laboratory, New York, 1986).

  47. Kieny, M. P. et al. Biol Technology 4, 790–795 (1986).

    CAS  Google Scholar 

  48. Clertant, P., Gaudray, P., May, E. & Cuzin, F. J. biol. Chem. 259, 15196–15293 (1984).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lathe, R., Kieny, M., Gerlinger, P. et al. Tumour prevention and rejection with recombinant vaccinia. Nature 326, 878–880 (1987). https://doi.org/10.1038/326878a0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/326878a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing